Epigenomics AG (EPGNF)
2.50
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Epigenomics Total Assets (Quarterly): 4.583M for June 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 4.583M |
| March 31, 2023 | 12.08M |
| December 31, 2022 | 17.00M |
| September 30, 2022 | 18.65M |
| June 30, 2022 | 21.54M |
| March 31, 2022 | 25.04M |
| December 31, 2021 | 27.92M |
| September 30, 2021 | 31.33M |
| June 30, 2021 | 11.53M |
| March 31, 2021 | 11.14M |
| December 31, 2020 | 8.36M |
| September 30, 2020 | 10.37M |
| June 30, 2020 | 12.42M |
| March 31, 2020 | 14.95M |
| December 31, 2019 | 15.67M |
| September 30, 2019 | 14.18M |
| June 30, 2019 | 17.68M |
| March 31, 2019 | 20.95M |
| December 31, 2018 | 24.97M |
| September 30, 2018 | 14.51M |
| June 30, 2018 | 16.38M |
| March 31, 2018 | 20.58M |
| December 31, 2017 | 23.72M |
| September 30, 2017 | 26.37M |
| June 30, 2017 | 14.70M |
| Date | Value |
|---|---|
| March 31, 2017 | 16.40M |
| December 31, 2016 | 19.26M |
| September 30, 2016 | 13.92M |
| June 30, 2016 | 19.83M |
| March 31, 2016 | 14.57M |
| December 31, 2015 | 13.77M |
| September 30, 2015 | 16.04M |
| June 30, 2015 | 16.90M |
| March 31, 2015 | 11.42M |
| December 31, 2014 | 13.77M |
| September 30, 2014 | 9.892M |
| June 30, 2014 | 13.54M |
| March 31, 2014 | 15.77M |
| December 31, 2013 | 15.30M |
| September 30, 2013 | 8.090M |
| June 30, 2013 | 9.402M |
| March 31, 2013 | 11.76M |
| December 31, 2012 | 9.096M |
| September 30, 2012 | 13.56M |
| June 30, 2012 | 17.11M |
| March 31, 2012 | 22.03M |
| December 31, 2011 | 25.21M |
| September 30, 2011 | 33.61M |
| June 30, 2011 | 40.96M |
| March 31, 2011 | 44.03M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.583M
Minimum
Jun 2023
31.33M
Maximum
Sep 2021
16.14M
Average
14.95M
Median
Mar 2020
Total Assets (Quarterly) Benchmarks
| Affimed NV | 107.40M |
| InflaRx NV | 115.65M |
| MorphoSys AG | 2.240B |
| BioNTech SE | 24.04B |
| Immatics NV | 705.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.508M |
| Shareholders Equity (Quarterly) | 2.075M |
| Current Ratio | 1.934 |